Clinical Interventions Reporting
April 23, 2012
There can be no more important
role for the pharmacist than the
one they perform as a check on
medications management and use.
Intervening to stop medication
errors, ensuring compliance and
identifying the potential for
adverse drug interactions has a
significant impact on the health of
Australians.
That’s something, as
pharmacists, that we understand
only too well.
These clinical interventions
deliver substantial return on
investment for government,
helping to balance a budget that is
stretched to capacity given the
prevailing economic climate.
This was quantified with the
release of Deloitte’s PROMISe III
report and Business Case for the
national implementation of the
PROMISe Program
That report estimated each
clinical intervention would deliver
savings of $367 in ongoing medical
expenses which would otherwise
be borne by the health system.
Based on that estimate, at Terry
White Chemists we are currently
on track to deliver $31 million in
savings this calendar year via
85,000 reported clinical
interventions throughout our
network of pharmacies.
We know that others are
similarly championing the cause
for greater reporting of this vital
pharmacy function.
Clinical interventions are not
new - they are a fundamental
function of pharmacies.
However at a time when
pharmacists are increasingly called
upon to defend our position in the
health system, greater reporting
of clinical interventions is vital and
can go a long way towards
securing broad-based support.
This week’s contributor is
Ivor North, Terry Chris
Campbell, Terry
White Chemists
Professional
Services
Pharmacist
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Apr 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Apr 12
